InvOpps IV US L.P. 13D and 13G filings for Oyster Point Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-05 4:32 pm Sale | 2023-01-03 | 13D | Oyster Point Pharma, Inc. OYST | InvOpps IV US L.P. | 0 0.000% | -2,768,586 (Position Closed) | Filing |
| 2022-12-20 5:41 pm Purchase | 2022-12-13 | 13D | Oyster Point Pharma, Inc. OYST | InvOpps IV US L.P. | 2,768,586 10.300% | 2,768,586 (New Position) | Filing |